Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Asthma Clinical Remission: The Benchmarks for Eliminating Airway Inflammation and Symptoms

Asthma Clinical Remission: The Benchmarks for Eliminating Airway Inflammation and Symptoms

Fractional exhaled nitric oxide (Feno)

Fractional exhaled nitric oxide (Feno)

Unveiling Significance of Time in Range: Value as key Glycemic Biomarker

Unveiling Significance of Time in Range: Value as key Glycemic Biomarker

Need to redefine the treatment paradigm Post OAD

Need to redefine the treatment paradigm Post OAD

SoliCGM Synergy: Soliqua’s Synchronized Impact on T2DM CGM Dynamics Therapy

SoliCGM Synergy: Soliqua’s Synchronized Impact on T2DM CGM Dynamics Therapy

The Evolving Role of Treatment and Technology in Diabetes Care

The Evolving Role of Treatment and Technology in Diabetes Care

Time-in-Range: A Key Determinant of Quality of Life

Time-in-Range: A Key Determinant of Quality of Life

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

The ATOS Study: Real-World Study on Effectiveness of Insulin Glargine U300 in the Gulf Region.

What Are the Signs and Symptoms of ASMD?

What Are the Signs and Symptoms of ASMD?

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

An Evidence about The Role of Basal Insulin Glargine 300 U/mL Post-GLP-1 Therapy

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens